Findings in Blood-Based Biomarkers for Prostate Cancer, Vaccines for Malignant Melanoma and Solid Tumors, Racial Differences in Aggressive Breast Cancers Presented at 2016 ASCO Conference
Newswise — (NEW YORK, NY – June 3, 2016) The 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) will include several research presentations by investigators from The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai. More than 30,000 oncology professionals from around the world will attend the conference, held June 3 to 7 in Chicago at McCormick Place, where presentations will cover the latest findings across oncology.
Here is a look at select studies Mount Sinai researchers are presenting at the meeting:
Myeloma: High-Risk Smoldering MyelomaOral Presentation: Ajai Chari, MD - Presenter Embargo: Friday, June 3, 4:24 pm
Lung Cancer: phase II multicenter, randomized, placebocontrolled, double-blind study of CC-486 plus pembrolizumab (pembro) vs pembro plus placebo in previously treated patients with locally advanced/metastatic nonsmall cell lung cancerAbstract TPS9107: Benjamin Levy, MD - Presenter Embargo: Friday, June 3, 4:24 pm
Prostate Cancer: Blood-based predictive biomarkers for overall survival in patients receiving immunotherapyAbstract 283: William K. Oh, MD - Presenter Embargo: Saturday, June 4, 1:00 pm
Melanoma: Dendritic Cell Targeting NY-ESO-1 Vaccine in Patients with Malignant MelanomaAbstract 194: Nina Bhardwaj, MD, PhD - Presenter Embargo: Saturday, June 4, 1:00 pm
Immunotherapy: PD-L1 Immune Checkpoints Using JEDI CellsAbstract 398: Ranjan Upadhyay, MD - Presenter Embargo: Sunday, June 5, 8:00 am
Immunotherapy: Therapeutic vaccination against drug-resistant solid cancers with Poly-ICLCAbstract 408: Chrisann Kyi, MD - Presenter Embargo: Sunday, June 5, 8:00 am
Sarcoma: Doxorubicin as an active treatment option for desmoid tumor patients Abstract 158: Angela Pang, MD - Presenter Embargo: Monday, June 6, 8:00 am
Breast Cancer: Are racial differences in obesity and insulin resistance related to aggressiveness in breast cancer?Abstract 391: Emily Gallagher, MD - Presenter Embargo: Monday, June 6, 8:00 am
Leukemia/Myelodysplastic Syndromes/Allotransplant: Rigosertib in combination with azacitidine to modulate epigenetic effects and to overcome clinical resistance in myelodysplastic syndromes Abstract 12: Pratima Chaurasia, MD – Presenter Embargo: Monday, June 6, 8:00 am
Gastrointestinal Stromal Tumors and Beyond: New Targets and Novel TherapiesMeet the Professor Session: Robert Maki, MD – Presenter Embargo: Monday, June 6, 3:00 pm
Bladder and Adrenal Cancer: New Immune Therapy Targets, Agents, and Populations in Bladder and Adrenal Cancer Oral Discussion, Arie Crown Theater: Matthew Galsky, MD – Presenter Embargo: Monday, June 6, 5:21 pm
Lymphoid Malignancies: Which Functional Imaging Functions the Best?Clinical Science Symposium: Lale Kostakoglu, MD – Presenter Embargo: Tuesday, June 7, 8:12 am
Myeloma: Checkpoint Blockade in MyelomaClinical Science Symposium: Hearn Cho, MD – Presenter Embargo: Tuesday, June 7, 10:21 am
About the Mount Sinai Health System
The Mount Sinai Health System is an integrated health system committed to providing distinguished care, conducting transformative research, and advancing biomedical education. Structured around seven hospital campuses and a single medical school, the Health System has an extensive ambulatory network and a range of inpatient and outpatient services—from community-based facilities to tertiary and quaternary care. The System includes approximately 7,000 primary and specialty care physicians; 12 joint-venture ambulatory surgery centers; more than 140 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and 31 affiliated community health centers. Physicians are affiliated with the renowned Icahn School of Medicine at Mount Sinai, which is ranked among the highest in the nation in National Institutes of Health funding per investigator. The Mount Sinai Hospital is ranked as one of the nation’s top 10 hospitals in Geriatrics, Cardiology/Heart Surgery, and Gastroenterology, and is in the top 25 in five other specialties in the 2014-2015 “Best Hospitals” issue of U.S. News & World Report. Mount Sinai’s Kravis Children’s Hospital also is ranked in seven out of ten pediatric specialties by U.S. News & World Report. The New York Eye and Ear Infirmary of Mount Sinai is ranked 11th nationally for Ophthalmology, while Mount Sinai Beth Israel is ranked regionally. For more information, visit http://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.
# # #
RSS